Instrumentation Monthly Test | Measurement | Control
Sense Biodetection has today announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Sense is partnering closely with Phillips-Medisize, a Molex company and leading global medical device innovator, developer and manufacturer, to scale-up production of its …
Read More »Sense accelerates instrument-free molecular diagnostic test for COVID-19
